| Bioactivity | JB002 is a myosin II inhibitor, with an IC50 of ≤10 μM. JB002 can be used for the research of muscle spasticity, chronic musculoskeletal pain, and hypertrophic cardiomyopathy[1]. |
| Target | IC50: ≤10 μM (myosin II) |
| Invitro | JB002 在心脏和骨骼肌球蛋白之间表现出良好的选择性，但对非肌肉 IIB 没有可检测的活性[1]。 |
| Name | JB002 |
| CAS | 30408-07-2 |
| Formula | C18H15NO3 |
| Molar Mass | 293.32 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
| Reference | [1]. Smith JD, et, al. Isoform selectivities of novel 4-hydroxycoumarin imines as inhibitors of myosin II. Eur J Med Chem. 2022 Dec 12;247:115008. |